SAVIMS

SAVIMS logo white
Menu

Other repurposed substances

COVID-19, Covid-19 vaccines, Epidemiological surveillance, Other repurposed substances, Peer-reviewed evidence, Resource Type, Statistical evidence, Treatment, Vaccines, Viral illnesses

Clinical Approach to Post-Acute Sequelae After COVID-19 Infection and Vaccination

| | COVID-19, Covid-19 vaccines, Epidemiological surveillance, Other repurposed substances, Peer-reviewed evidence, Resource Type, Statistical evidence, Treatment, Vaccines, Viral illnesses

Reference: Hulscher, N., Procter, B. C., Wynn, C., & McCullough, P. A. (2023). Clinical approach to post-acute sequelae after COVID-19 infection and vaccination. Cureus, 15(11), e49204. https://doi.org/10.7759/cureus.49204 Summary: The article explores the pathogenic characteristics of the SARS-CoV-2 spike protein and its potential role in post-acute sequelae following COVID-19 infection or vaccination. It highlights emerging evidence […]

COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Comprehensive Overview of Early COVID-19 Treatment Protocols

| | COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Reference: FLCCC Alliance. (2023). I-CARE early COVID treatment summary. Retrieved from https://www.flccc.net Summary: The FLCCC Alliance outlines a structured protocol for the early treatment of COVID-19, emphasising the importance of immediate intervention after the onset of symptoms. First-line treatments include Ivermectin (0.4-0.6 mg/kg), Hydroxychloroquine (200 mg twice daily), and antiseptic mouthwash for symptom management. Ivermectin

COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

I-CARE Early COVID Treatment Protocol Overview

| | COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Reference: FLCCC Alliance. (2023). I-CARE: Early COVID treatment protocol. Retrieved from [insert link] Summary: The I-CARE protocol, developed by the FLCCC Alliance, aims to provide healthcare professionals with a structured approach to early COVID-19 treatment, focusing on preventing hospitalisation and mortality. The protocol recommends a combination of first-line treatments such as ivermectin, hydroxychloroquine, and various

COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Comprehensive Prevention Strategies Against COVID-19, Influenza, and RSV – SUMMARY

| | COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Reference: FLCCC Alliance. (2023). I-PREVENT COVID, FLU AND RSV protection. Retrieved from www.flccc.net Summary: The I-PREVENT protocol is designed for healthcare workers, high-risk individuals, and those with co-morbidities to mitigate the risks of COVID-19, influenza, and RSV infections. Recommended interventions include antiseptic mouthwashes containing chlorhexidine, povidone-iodine, or cetylpyridinium chloride, and supplementation with Vitamin D, Vitamin

COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Other viral illnesses, Resource Type, Treatment, Viral illnesses

Preventative Protocols for COVID-19, Influenza, and RSV

| | COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Other viral illnesses, Resource Type, Treatment, Viral illnesses

Reference: I-PREVENT. (2023). COVID, Flu and RSV protection. Retrieved from [source link if applicable, otherwise remove this line] Summary: The I-PREVENT protocol offers strategies for the prevention of COVID-19, influenza, and RSV. It includes pre-exposure and post-exposure prevention measures, particularly aimed at high-risk groups and healthcare workers. The pre-exposure approach recommends the use of antiseptic

COVID-19, Ivermectin, Other repurposed substances, Peer-reviewed evidence, Resource Type, Treatment, Viral illnesses

Efficacy of Metformin, Ivermectin, and Fluvoxamine in Early COVID-19 Treatment

| | COVID-19, Ivermectin, Other repurposed substances, Peer-reviewed evidence, Resource Type, Treatment, Viral illnesses

Reference: Bramante, C. T., Huling, J. D., Tignanelli, C. J., Buse, J. B., Liebovitz, D. M., Nicklas, J. M., Cohen, K., Puskarich, M. A., Belani, H. K., Proper, J. L., Siegel, L. K., Klatt, N. R., Odde, D. J., Luke, D. G., Anderson, B., Karger, A. B., Ingraham, N. E., Hartman, K. M., Rao, V.,

COVID-19, Covid-19 vaccines, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Vaccines, Viral illnesses

Management of Post-Vaccine Syndrome: I-RECOVER Protocol

| | COVID-19, Covid-19 vaccines, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Vaccines, Viral illnesses

Reference: Marik, P. E., Kory, P., & Contributors. (2022). I-RECOVER: Post-Vaccine Treatment protocol (5/25/2022). An Approach to the Management of Post-Vaccine Syndrome. Summary: The I-RECOVER protocol is designed to aid healthcare professionals in managing patients with post-vaccine syndrome, a condition arising from COVID-19 vaccinations. While no formal definition exists, symptoms correlating temporally with vaccination can

COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Comprehensive COVID-19 Management Protocols

| | COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Reference: Marik, P. (2022. COVID-19 management protocol. FLCCC Alliance. Retrieved from www.flccc.net Summary: The FLCCC Alliance’s COVID-19 Management Protocol, developed by Dr Paul Marik, outlines strategies for managing COVID-19 through three primary protocols: MATH+, I-MASK+, and I-RECOVER. The MATH+ protocol focuses on treating patients in the pulmonary phase, utilising anti-inflammatory therapies and corticosteroids to reduce

COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Comprehensive Overview of the I-MASK+ Protocol for COVID-19 Treatment

| | COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Reference: FLCCC Alliance. (2021). I-MASK+ protocol: Prevention and early outpatient treatment protocol for COVID-19 (Version 18). Retrieved from https://www.flccc.net/covid-19-protocols Summary: The I-MASK+ protocol, developed by the Front Line COVID-19 Critical Care Alliance (FLCCC), is designed for the prevention and early outpatient treatment of COVID-19, particularly against the Delta variant. It emphasises the use of ivermectin

Scroll to Top